Julia, AntonioGomez, AntonioLopez-Lasanta, MariaBlanco, FranciscoErra, AlbaFernandez-Nebro, AntonioMas, Antonio JuanPerez-Garcia, CarolinaGarcia-Vivar, Ma LuzSanchez-Fernandez, SimonAlperi-Lopez, MercedesSanmarti, RaimonOrtiz, Ana MariaFernandez-Cid, Carlos MarrasDiaz-Torne, CesarMoreno, EstefaniaLi, TianluMartinez-Mateu, Sergio HAbsher, Devin MMyers, Richard MMolina, Jesus TorneroMarsal, Sara2023-05-032023-05-032022-05-13Julià A, Gómez A, López-Lasanta M, Blanco F, Erra A, Fernández-Nebro A, et al. Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis. EBioMedicine. 2022 Jun;80:104053http://hdl.handle.net/10668/22163Rheumatoid arthritis (RA) is a chronic, immune-mediated inflammatory disease of the joints that has been associated with variation in the peripheral blood methylome. In this study, we aim to identify epigenetic variation that is associated with the response to tumor necrosis factor inhibitor (TNFi) therapy. Peripheral blood genome-wide DNA methylation profiles were analyzed in a discovery cohort of 62 RA patients at baseline and at week 12 of TNFi therapy. DNA methylation of individual CpG sites and enrichment of biological pathways were evaluated for their association with drug response. Using a novel cell deconvolution approach, altered DNA methylation associated with TNFi response was also tested in the six main immune cell types in blood. Validation of the results was performed in an independent longitudinal cohort of 60 RA patients. Treatment with TNFi was associated with significant longitudinal peripheral blood methylation changes in biological pathways related to RA (FDR Our results show that treatment with TNFi restores homeostatic blood methylation in RA. The clinical response to TNFi is associated to methylation variation in specific biological pathways, and it involves cells from both the innate and adaptive immune systems. The Instituto de Salud Carlos III.enAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/DNA methylationEpigeneticsRheumatoid arthritisTNF inhibitorsTreatment responseAntirheumatic AgentsArthritis, RheumatoidCohort StudiesDNA MethylationHumansTumor Necrosis Factor InhibitorsTumor Necrosis Factor-alpharesearch article35576644open accessMetilación de ADNEpigenomaInhibidores del factor de necrosis tumoralSistema inmunológicoArtritis reumatoideEpigenómica10.1016/j.ebiom.2022.1040532352-3964PMC9118662http://www.thelancet.com/article/S2352396422002341/pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118662/pdf